MyBCTeam

For someone who is 82 years old, has undergone a lumpectomy with clear edges and no lymph node involvement, and has ER+ (estrogen receptor-positive), HER2+ (human epidermal growth factor receptor 2-positive), and BRCA+ (BRCA gene mutation) breast cancer, the recurrence risk can be influenced by several factors:

1. ER+ Show Full Answer

For someone who is 82 years old, has undergone a lumpectomy with clear edges and no lymph node involvement, and has ER+ (estrogen receptor-positive), HER2+ (human epidermal growth factor receptor 2-positive), and BRCA+ (BRCA gene mutation) breast cancer, the recurrence risk can be influenced by several factors:

1. ER+ Status: ER-positive breast cancer can recur later, more than five years after treatment is completed.
2. HER2+ Status: HER2-positive breast cancer has a higher recurrence rate, with many recurrences happening within the first few years after diagnosis.
3. BRCA+ Status: BRCA mutations can increase the risk of recurrence and new cancers.

While specific statistics on recurrence time frames without chemotherapy are not provided in the knowledge base, it is important to note that:

- Close Monitoring: Regular follow-ups with your doctor are crucial to monitor for signs of recurrence.
- Hormone Therapy: For ER-positive cancers, hormone therapy like tamoxifen can help reduce the risk of recurrence.
- Healthy Lifestyle: Maintaining a healthy weight, exercising regularly, and reducing alcohol intake can also help lower the risk of recurrence.

Consulting with your healthcare provider for personalized advice and considering all treatment options, including the potential benefits of chemotherapy, is essential.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

Triple-Negative Breast Cancer Recurrence Rate: 8 Things to Know | MyBCTeam

When Is HER2-Positive Breast Cancer Most Likely To Recur? | MyBCTeam